[1]
Jalbert, J.J. et al. 2017. EFFECT OF AN INSTITUTIONAL MEDICATION ADHERENCE PROGRAM FOR LONG-ACTING INJECTABLE RISPERIDONE ON ADHERENCE AND PSYCHIATRIC HOSPITALIZATIONS: EVIDENCE FROM A PROSPECTIVE COHORT STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 24, 2 (Jun. 2017), e61-e70. DOI:https://doi.org/10.22374/1710-6222.24.2.7.